Literature DB >> 3792374

Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part I. Chemistry and labeling technique.

J Schuhmacher, R Matys, H Hauser, W Maier-Borst, S Matzku.   

Abstract

As a chelating agent for labeling antibodies (Abs) with metallic radionuclides, a propionic acid substituted ethylenediamine N,N'-di-[(o-hydroxyphenyl) acetic acid] (P-EDDHA), which tightly complexes 67Ga, was synthesized. The 67Ga-P-EDDHA chelate was coupled in aqueous solution to IgG at a molar ratio of 1:1 via carbodiimide. The average coupling yield was 15%. A specific activity of 4 mCi/mg IgG could be obtained with commercially supplied 67Ga. In vitro stability was evaluated in human serum at 37 degrees C and showed a half-life of about 120 h for the release of 67Ga from the labeled Ab during the initial phase of incubation. This in vitro halflife is similar to that measured for 111In-DTPA labeled Abs. Because of the high stability of the 67Ga-P-EDDHA chelate, the in vivo formation of radioactive labeled transferrin by transchelation, as described for 111In-DTPA labeled Abs, should, however, be reduced by this labeling technique.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792374     DOI: 10.1007/bf00252198

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  25 in total

1.  The attachment of metal-chelating groups to protein: tagging of albumin by diazonium coupling and use of the products as radiopharmaceuticals.

Authors:  C S Leung; C F Meares; D A Goodwin
Journal:  Int J Appl Radiat Isot       Date:  1978-11

2.  Formation constants of gallium- and indium-transferrin.

Authors:  S Kulprathipanja; D J Hnatowich; R Beh; D Elmaleh
Journal:  Int J Nucl Med Biol       Date:  1979

3.  The stability constants of the iron-transferrin complex.

Authors:  B DAVIS; P SALTMAN; S BENSON
Journal:  Biochem Biophys Res Commun       Date:  1962-06-19       Impact factor: 3.575

4.  Iron metabolism in man.

Authors:  S KORMAN
Journal:  Ann N Y Acad Sci       Date:  1960-08-18       Impact factor: 5.691

Review 5.  Monoclonal antibodies in nuclear medicine.

Authors:  A M Keenan; J C Harbert; S M Larson
Journal:  J Nucl Med       Date:  1985-05       Impact factor: 10.057

6.  The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients.

Authors:  M V Pimm; A C Perkins; N C Armitage; R W Baldwin
Journal:  J Nucl Med       Date:  1985-09       Impact factor: 10.057

7.  The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy.

Authors:  A C Perkins; M V Pimm; M K Birch
Journal:  Eur J Nucl Med       Date:  1985

8.  [56] Carbodiimide modification of proteins.

Authors:  K L Carraway; D E Koshland
Journal:  Methods Enzymol       Date:  1972       Impact factor: 1.600

9.  The preparation and labeling of DTPA-coupled albumin.

Authors:  D J Hnatowich; W W Layne; R L Childs
Journal:  Int J Appl Radiat Isot       Date:  1982-05

10.  Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.

Authors:  R A Fawwaz; T S Wang; A Estabrook; J M Rosen; M A Hardy; P O Alderson; S C Srivastava; P Richards; S Ferrone
Journal:  J Nucl Med       Date:  1985-05       Impact factor: 10.057

View more
  2 in total

Review 1.  Clinical applications of Gallium-68.

Authors:  Sangeeta Ray Banerjee; Martin G Pomper
Journal:  Appl Radiat Isot       Date:  2013-02-20       Impact factor: 1.513

2.  Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies.

Authors:  Matthias Eder; Björn Wängler; Stefan Knackmuss; Fabrice LeGall; Melvyn Little; Uwe Haberkorn; Walter Mier; Michael Eisenhut
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-29       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.